武清区龙济医院泌尿外科割包皮要多少钱(武清龙济医院怎么样男科怎么样) (今日更新中)

SAN FRANCISCO, May 6 (Xinhua) -- Bud Tribble, Apple's vice president of software technology, will testify at the Congressional hearings on mobile privacy next week, according to the witness list released on Friday.Tribble will represent Apple at the hearings of the U.S. Senate Judiciary Subcommittee on Privacy, Technology and the Law. The hearings, entitled "Protecting Mobile Privacy: Your Smartphones, Tablets, Cell Phones and Your Privacy," is scheduled to take place next Tuesday in the wake of an iPhone location database controversy.Tribble is one of the industry's top experts in software design and object-oriented programming, known for helping to design the Mac OS and user interface. He is considered as the right-hand man of Apple CEO Steve Jobs and has been with Jobs since they developed the original Macintosh. When Jobs was forced to resign from Apple in 1985, Tribble followed Jobs and co-founded another computer company NeXT Computer. He rejoined Apple and Jobs in 2002.At the upcoming Congressional hearing, Tribble will be joined by Alan Davidson, Google's director of public policy for the Americas.Apple has been under heavy fire after it was alleged last month that its iphones and other smart phones had been collecting customers' location information. In the wake of the controversy, U. S. senator Al Franken, chairman of the Senate Judiciary Subcommittee on Privacy, Technology and the Law, scheduled the mobile privacy hearing and asked representatives from Apple and Google to testify.Apple has denied the alleged practice and released software updates to make iPhone store less location information to quell public concerns over privacy.

VIENNA, March 28 (Xinhua) -- Stress hormone is helpful in alleviating acrophobia, a morbid fear of great heights, according to a study by Austrian scientists.They published the findings in the recent Proceedings of the National Academy of Sciences of the United States of America.Frank H. Wilhelm, professor from the Department of Clinical Psychology, Psychotherapy and Health Psychology at the University of Salzburg, Austria, carried out the first study demonstrating the clinical effectiveness of hormones released at periods of high stress in anxiety.The study found hormones and other drugs could be a good addition to behavioral treatment of several anxiety disorders.People with acrophobia have formed a so-called fear memory, which could be activated when the fear-causing stimulus occurs. They tend to react with feelings of extreme fear and anxiety to the ride in a glass elevator.Hence, scientists conducted a confrontation therapy, trying to mask this memory.A total of 40 experimental subjects had been put in a safe environment to constantly confront the fear-inducing stimulus, until they had a new reaction to the perceived threat.Observations also suggested hormones released in high stress had impact on learning and memory.Additionally, stress hormones were believed to facilitate the storage of new, anxiety-free competence and experienced confidence in the therapy. Animal studies have shown that this emotional relearning benefits from cortisol, one of the stress hormones.

WASHINGTON, March 24 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Thursday approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older.In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year. It is a disease caused by the varicella-zoster virus, which is a virus in the herpes family and the same virus that causes chickenpox.After an attack of chickenpox, the virus lies dormant in certain nerves in the body. For reasons that are not fully understood, the virus can reappear in the form of shingles, more commonly in people with weakened immune systems and with aging."The likelihood of shingles increases with age. The availability of Zostavax to a younger age group provides an additional opportunity to prevent this often painful and debilitating disease" said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement. ( Shingles is characterized by a rash of blisters, which generally develop in a band on one side of the body and can cause severe pain that may last for weeks, and in some people, for months or years after the episode.Approval was based on a multicenter study conducted in the United States and four other countries in approximately 22,000 people who were 50-59 years of age. Half received Zostavax and half received a placebo. Study participants were then monitored for at least one year to see if they developed shingles. Compared with placebo, Zostavax reduced the risk of developing shingles by approximately 70 percent.The most common side effects observed in the study were redness, pain and swelling at the site of injection, and headache, according to the FDA.Zostavax, manufactured by Merck & Co., was originally approved on May 26, 2006, for the prevention of shingles in individuals 60 years of age and older.

BEIJING, Feb. 5 (Xinhua) -- China's railways transported about 77.34 million passengers during the fifteen days (Jan. 19 to Feb. 2) before the Spring Festival, the Ministry of Railways said.The figure was about 9.5 percent higher than the same period last year and set a new record, according to a report posted on the ministry's website.There were an average of 5.16 million passengers per day, up 448,000 from the same period last year. On Jan. 29, passengers topped 5.78 million, setting a new record for daily transportation before the Spring Festival, the report said.In the fifteen days before the festival, about 4.80 million passengers left Beijing, 8.39 million left Guangzhou and 5.69 million left Shanghai, while year-on-year growth and those leaving Guangzhou rose the most, up 15 percent year on year, said the report.The ministry said challenges still exist as more snow and rain will hit southern China after the Spring Festival, when passengers are returning.China's busy Spring Festival transportation season runs for 40 days and is calculated in two phases: 15 days before the Spring Festival and 25 days after the Spring Festival, the report explained.

DAVOS, Switzerland, Jan. 29 (Xinhua) -- China is ready to push the decade-long Doha Round negotiations for a final success, Chinese Minister of Commerce Chen Deming said here on Saturday.Speaking at the World Trade Organization (WTO) Mini-Ministerial Meeting which brought together representatives from over 20 major trading powers, Chen said that China is ready to collaborate with other WTO members in a practical and proactive manner so as to draw a successful conclusion of the Doha Round talks by the end of 2011.A rapid conclusion of the negotiations, Chen said, will be beneficial to global economic recovery, which is to the interest of all.The commerce minister acknowledged the year 2011 as a "window of opportunity," albeit a narrow one."China will give support to the roadmap proposed by WTO Director-General Pascal Lamy," he said, adding that the country is willing to act vigorously to push forward the negotiation process.To ensure that an early final deal could be in reach, Chen said, parties should set goals in a practical manner, in accordance with the ambition level, and stick to what has been achieved as well as the Doha Development Agenda (DDA), while focusing primarily on pending issues.Held on the sidelines of the annual World Economic Forum, the WTO Mini-Ministerial Meeting is an annual event under the auspices of the Swiss Federal Government.Chen on Friday also joined discussions with his counterparts from the emerging club -- India, Brazil and South Africa, before attending the trade G7 meeting, consisting of Australia, Brazil, China, the European Union, India, Japan and the United States.

来源：资阳报